215 related articles for article (PubMed ID: 26919318)
1. Selective Killing Effects of Cold Atmospheric Pressure Plasma with NO Induced Dysfunction of Epidermal Growth Factor Receptor in Oral Squamous Cell Carcinoma.
Lee JH; Om JY; Kim YH; Kim KM; Choi EH; Kim KN
PLoS One; 2016; 11(2):e0150279. PubMed ID: 26919318
[TBL] [Abstract][Full Text] [Related]
2. Cold Atmospheric Pressure Plasma-Activated Medium Induces Selective Cell Death in Human Hepatocellular Carcinoma Cells Independently of Singlet Oxygen, Hydrogen Peroxide, Nitric Oxide and Nitrite/Nitrate.
Li Y; Tang T; Lee H; Song K
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074016
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial Effect of Cold Atmosphere Plasma (CAP) and the Anticancer Drug Cisplatin on Oral Squamous Cell Cancer Therapy.
Lee CM; Jeong YI; Kook MS; Kim BH
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076565
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effects of Non-Thermal Atmospheric Pressure Plasma on Migration and Invasion in Oral Squamous Cell Cancer, by Gas Type.
Kang SU; Seo SJ; Kim YS; Shin YS; Koh YW; Lee CM; Yang SS; Lee JS; Moon E; Kang H; Ryeo JB; Lee Y; Kim CH
Yonsei Med J; 2017 Mar; 58(2):272-281. PubMed ID: 28120556
[TBL] [Abstract][Full Text] [Related]
5. Lupeol evokes anticancer effects in oral squamous cell carcinoma by inhibiting oncogenic EGFR pathway.
Rauth S; Ray S; Bhattacharyya S; Mehrotra DG; Alam N; Mondal G; Nath P; Roy A; Biswas J; Murmu N
Mol Cell Biochem; 2016 Jun; 417(1-2):97-110. PubMed ID: 27206736
[TBL] [Abstract][Full Text] [Related]
6. The inhibition effect of cold atmospheric plasma-activated media in cutaneous squamous carcinoma cells.
Wang L; Yang X; Yang C; Gao J; Zhao Y; Cheng C; Zhao G; Liu S
Future Oncol; 2019 Feb; 15(5):495-505. PubMed ID: 30648877
[TBL] [Abstract][Full Text] [Related]
7. Anti-EGFR antibody cetuximab is secreted by oral squamous cell carcinoma and alters EGF-driven mesenchymal transition.
Fujiwara T; Eguchi T; Sogawa C; Ono K; Murakami J; Ibaragi S; Asaumi JI; Okamoto K; Calderwood SK; Kozaki KI
Biochem Biophys Res Commun; 2018 Sep; 503(3):1267-1272. PubMed ID: 30017201
[TBL] [Abstract][Full Text] [Related]
8. Cold atmospheric plasma and iron oxide-based magnetic nanoparticles for synergetic lung cancer therapy.
Li W; Yu H; Ding D; Chen Z; Wang Y; Wang S; Li X; Keidar M; Zhang W
Free Radic Biol Med; 2019 Jan; 130():71-81. PubMed ID: 30342190
[TBL] [Abstract][Full Text] [Related]
9. Non-thermal atmospheric pressure plasma induces apoptosis in oral cavity squamous cell carcinoma: Involvement of DNA-damage-triggering sub-G(1) arrest via the ATM/p53 pathway.
Chang JW; Kang SU; Shin YS; Kim KI; Seo SJ; Yang SS; Lee JS; Moon E; Baek SJ; Lee K; Kim CH
Arch Biochem Biophys; 2014 Mar; 545():133-40. PubMed ID: 24486404
[TBL] [Abstract][Full Text] [Related]
10. Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model.
Bhuvaneswari R; Ng QF; Thong PS; Soo KC
Oncotarget; 2015 May; 6(15):13487-505. PubMed ID: 25918252
[TBL] [Abstract][Full Text] [Related]
11. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members.
Xia W; Lau YK; Zhang HZ; Xiao FY; Johnston DA; Liu AR; Li L; Katz RL; Hung MC
Clin Cancer Res; 1999 Dec; 5(12):4164-74. PubMed ID: 10632356
[TBL] [Abstract][Full Text] [Related]
12. Effects of activated fibroblasts on phenotype modulation, EGFR signalling and cell cycle regulation in OSCC cells.
Berndt A; Büttner R; Gühne S; Gleinig A; Richter P; Chen Y; Franz M; Liebmann C
Exp Cell Res; 2014 Apr; 322(2):402-14. PubMed ID: 24394543
[TBL] [Abstract][Full Text] [Related]
13. Cold atmospheric plasma jet-generated RONS and their selective effects on normal and carcinoma cells.
Kim SJ; Chung TH
Sci Rep; 2016 Feb; 6():20332. PubMed ID: 26838306
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells.
Iwase M; Takaoka S; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M
Oral Oncol; 2008 Apr; 44(4):361-8. PubMed ID: 17689285
[TBL] [Abstract][Full Text] [Related]
15. ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.
Lu H; Li X; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Oct; 381(1):23-30. PubMed ID: 27450723
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of novel HSP90 inhibitor NVP-AUY922 against oral squamous cell carcinoma.
Okui T; Shimo T; Hassan NM; Fukazawa T; Kurio N; Takaoka M; Naomoto Y; Sasaki A
Anticancer Res; 2011 Apr; 31(4):1197-204. PubMed ID: 21508365
[TBL] [Abstract][Full Text] [Related]
17. The expression of epidermal growth factor receptors in the oral mucosa of patients with oral cancer.
Bergler W; Bier H; Ganzer U
Arch Otorhinolaryngol; 1989; 246(3):121-5. PubMed ID: 2474288
[TBL] [Abstract][Full Text] [Related]
18. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
19. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC
Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885
[TBL] [Abstract][Full Text] [Related]
20. Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma.
Benhamou Y; Picco V; Raybaud H; Sudaka A; Chamorey E; Brolih S; Monteverde M; Merlano M; Lo Nigro C; Ambrosetti D; Pagès G
Oncotarget; 2016 Jul; 7(28):44236-44251. PubMed ID: 27329590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
